Barely Significant
← all excerpts

Combination therapy targeting Alzheimer's disease risk factors is associated with a significant delay in Alzheimer's disease-related cognitive decline.

Alzheimers Dement (N Y) · 2025 · PMC11947753 · PMID 40151397

Europe PMCDOI
1
hedged sentence
0.0200
closest p · 0.4× alpha
0.0200
boldest claim

The sentences

difference was apparentP = 0.02actually significant
Sex differences A significant sex difference was apparent in the rate of progression of cognitive decline as measured by CDR‐SB in untreated NACC AD participants ( P = 0.02) with females associated with more rapid cognitive decline compared to males (Figure 3A , dashed lines).

also in 195 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.